An independent study also reported two RUNX1 mutations and four mutations in CBFB in ER+ luminal tumors [94], while Nik-Zainal and colleagues showed that both RUNX1 and CBFB were in the top 50 of 93 genes at risk of acquiring driver mutations in breast cancers [11]. Here, RUNX1 is linked to breast carcinoma.